New Swedish research reveals impaired kidney function nearly doubles dementia risk for people with early neurodegeneration markers. Over 37 million Americans with kidney disease may be vulnerable.
New research shows obesity can accelerate Alzheimer's disease progression, with blood tests proving more sensitive than brain scans. Discover the crucial link and potential for future treatments.
New research shows obesity can accelerate Alzheimer's biomarkers by up to 95%. Learn how blood tests are transforming dementia risk detection and what this means for future treatments in the UK.
Groundbreaking research reveals a simple blood test can detect ME/CFS biomarkers, offering hope for millions suffering from the misunderstood condition and potentially ending decades of diagnostic uncertainty.